Emerging therapies in multiple sclerosis

Author： Farrell Rachel Heaney Dominic Giovannoni Gavin

ISSN： 1472-8214

Source： Expert Opinion on Emerging Drugs, Vol.10, Iss.4, 2005-11, pp. : 797-816

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Emerging disease modifying therapies for multiple sclerosis

By Waubant Emmanuelle

Expert Opinion on Emerging Drugs, Vol. 8, Iss. 1, 2003-05 ,pp. : 145-161

Informa Healthcare

Access to resources Recommend Favorite

Antigen-specific therapies in multiple sclerosis

By Giacomini Paul S Bar-Or Amit

Expert Opinion on Emerging Drugs, Vol. 14, Iss. 3, 2009-09 ,pp. : 551-560

Informa Healthcare

Access to resources Recommend Favorite

Induction and Escalation Therapies in Multiple Sclerosis

Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Inflammatory and Anti-Allergy Agents), Vol. 14, Iss. 1, 2015-03 ,pp. : 26-34

Bentham Science Publishers

Access to resources Recommend Favorite

Emerging oral drugs for relapsing–remitting multiple sclerosis

By Gasperini Claudio Ruggieri Serena

Expert Opinion on Emerging Drugs, Vol. 16, Iss. 4, 2011-12 ,pp. : 697-712

Informa Healthcare

Access to resources Recommend Favorite

Multiple Sclerosis: Emerging Opportunities for Therapeutic Intervention

Current Drug Targets-CNS & Neurological Disorders, Vol. 1, Iss. 1, 2002-01 ,pp. : 17-30

Bentham Science Publishers

Access to resources Recommend Favorite